Cision Mediastudio View Media The homepage of the gsk usa websitejuly 24 2025 gsk sponsors 2025 national senior games as part of sideline rsv campaign to raise awareness of rsv in older adults july 23 2025 gsk announces extension of us food and drug administration review period for blenrep (belantamab mafodotin blmf) in relapsed refractory multiple myeloma july 17 2025 gsk provides update on us fda advisory committee. The business is therefore well positioned to deliver human health impact and to sustainably grow ahead of the market in the years to come. the new name was announced as part of a global celebration for all of the people working in gsk consumer healthcare earlier today.
Gsk Consumer Healthcare Get Products From Gsk Consumer Healthcare On Gsk plc (nyse: gsk) has completed the demerger of the consumer healthcare business to form the haleon group. reuters reported that shares in haleon started trading at 330 pence on monday morning. British drugmaker gsk will spin off its consumer health business haleon worth up to an estimated 48 billion pounds ($57 billion) on monday in the biggest listing in europe in over a decade. On june 23, 2021, glaxosmithkline plc (nyse: gsk, $40.45, market cap: $101.8 billion) announced that it plans to spin off its consumer healthcare division into a separately listed company. the. Glaxosmithkline is due to complete the split from its consumer health decision – now renamed haleon – next month, with a listing for the new company on the london stock exchange set for 18 july.
Gsk To Name Consumer Healthcare Unit Haleon After Spin Off On june 23, 2021, glaxosmithkline plc (nyse: gsk, $40.45, market cap: $101.8 billion) announced that it plans to spin off its consumer healthcare division into a separately listed company. the. Glaxosmithkline is due to complete the split from its consumer health decision – now renamed haleon – next month, with a listing for the new company on the london stock exchange set for 18 july. The combined business, which will operate globally as gsk consumer healthcare, will be led by ceo brian mcnamara. “the successful closing of the joint venture represents an important and exciting step in forming a world class pure play consumer healthcare business,” said albert bourla, chief executive officer, pfizer. Gsk confirms it has received three proposals from unilever to acquire its consumer healthcare business, a jv with pfizer, but rejected them as undervaluing the business. gsk plans to demerge the business in mid 2022 and create a new global consumer company.
Gsk Consumer Healthcare Office Jason Williams The combined business, which will operate globally as gsk consumer healthcare, will be led by ceo brian mcnamara. “the successful closing of the joint venture represents an important and exciting step in forming a world class pure play consumer healthcare business,” said albert bourla, chief executive officer, pfizer. Gsk confirms it has received three proposals from unilever to acquire its consumer healthcare business, a jv with pfizer, but rejected them as undervaluing the business. gsk plans to demerge the business in mid 2022 and create a new global consumer company.